Furthermore, ACPAs purified from RA patient serum can additionally induce NLRP3-dependent IL-1β release from human granulocyte-macrophage colony-stimulating factor-derived macrophages [17]. The gene discussed is IL1B; the disease is rheumatoid arthritis.